Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-03-18

Clinical Trial Update: Assessing Tenapanor as a Treatment of CF-related Constipation. [Phase 3]

View source ↗

Summary

Phase 3 study evaluating tenapanor for constipation associated with cystic fibrosis is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Tenapanor (tenapanor)

Snippet

Sponsor: Massachusetts General Hospital | Conditions: Cystic Fibrosis, Constipation | Phase 3 | Status: RECRUITING